Cargando…

Monitoring of anti-TNF biological treatments

Detalles Bibliográficos
Autores principales:	Ruiz del Agua, A, Pascual-Salcedo, D, Balsa, A, Ramos, I, Novalbos, L, Ramiro, S, Martínez, A, Simón, L, Nagore, D
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3007776/ http://dx.doi.org/10.1186/1479-5876-8-S1-P32

Ejemplares similares

Understanding the biology and use of anti-TNF agents in JIA – interim results
por: Lovell, Daniel J, et al.
Publicado: (2012)

Synovial fibroblast hyperplasia correlates with rheumatoid arthritis duration and activity and is partially reversed by anti-TNF therapy
por: Izquierdo, E, et al.
Publicado: (2010)

Clinical and functional effectiveness of anti-TNF therapy in patients with rheumatoid arthritis
por: Martínez-Pérez, Rosalia, et al.
Publicado: (2011)

Anti-tumour necrosis factor (anti-TNF) in the treatment of juvenile idiopathic arthritis-associated uveitis
por: Rivarola, C, et al.
Publicado: (2008)

DNase I levels in JIA – influence of anti-TNF (etanercept) therapy
por: Vojinovic, J, et al.
Publicado: (2008)

Use of anti-TNF Etanercept in paediatric patients with autoimmune disease and ocular involvement: the Parma experience
por: Rossi, M, et al.
Publicado: (2008)

Predictors of response and anti-TNF drugs comparative efficacy
por: Canhão, Helena, et al.
Publicado: (2011)

Granulomatous inflammation in cartilage-hair hypoplasia: risks and benefits of anti-TNF alpha monoclonal antibodies
por: Moshous, D, et al.
Publicado: (2011)

Understanding the biology and use of TNF therapy in jia-clinical outcomes
por: Lovell, Daniel, et al.
Publicado: (2014)

PReS-FINAL-2265: Tuberculosis in pediatric patients who are receiving anti-TNF agents
por: Calzada-Hernández, J, et al.
Publicado: (2013)

PReS-FINAL-2314: Anti-TNF alpha therapy for refractory childhood takayasu arthritis
por: Koren, B, et al.
Publicado: (2013)

Tuberculosis in Juvenile Idiopathic arthritis under Anti-TNF therapy
por: Espada, G, et al.
Publicado: (2011)

Non-anti TNF biologic modifier drugs in non-infectious refractory chronic uveitis: the current evidence from a systematic review
por: Simonini, Gabriele, et al.
Publicado: (2014)

Use of TNF inhibitors in the treatment of PAPA syndrome
por: Stone, D, et al.
Publicado: (2015)

The immunogenicity to the first anti-TNF therapy determines the outcome of switching to a second anti-TNF therapy in spondyloarthritis patients
por: Plasencia, Chamaida, et al.
Publicado: (2013)

Efficacy and safety of anti-TNF agents in patients with enthesitis related arthritis
por: Tynjälä, P, et al.
Publicado: (2008)

Effects of anti-TNF therapy on ophtalmological complications in children with rheumatic diseases
por: Frkovic, Marijan, et al.
Publicado: (2014)

PReS-FINAL-2064: Effect of Goloimumab a new anti-TNF, in patients with the diagnosis of juvenile idiopathic arthritis
por: Kienast, A, et al.
Publicado: (2013)

Abatacept for severe anti-TNF-alfa refractory JIA-associated uveitis: one year follow-up
por: Alpigiani, MG, et al.
Publicado: (2011)

Safety of anti-TNF therapy: 10 year experience in pediatric patients from a single tertiary center
por: Espada, G, et al.
Publicado: (2011)

PReS-FINAL-2088: Risk of severe adverse events in juvenile idiopathic arthritis and pediatric-onset inflammatory bowel disease, treated with anti-tnf drugs
por: Vatta, P, et al.
Publicado: (2013)

Anakinra in systemic juvenile idiopathic arthritis (soJIA) non responsive to antiTNF
por: Pontikaki, I, et al.
Publicado: (2008)

Adverse events during anti-TNF therapy in 269 patients with juvenile idiopathic arthritis
por: Tarkiainen, M, et al.
Publicado: (2008)

TRAF1/C5 locus is associated with response to anti-TNF in rheumatoid arthritis
por: Canhão, Helena, et al.
Publicado: (2012)

Safety and tolerability of an ovine-derived polyclonal anti-TNFα Fab fragment (AZD9773) in patients with severe sepsis
por: Morris, P, et al.
Publicado: (2011)

TNFβ +250 polymorphism and hyperdynamic state in cardiac surgery with extracorporeal circulation
por: Iribarren, J, et al.
Publicado: (2009)

Influence of TNFα–308 and T676G TNF-RII polymorphism on response to etanercept and posibility to discontinue tretment
por: Vojinovic, J, et al.
Publicado: (2011)

PReS-FINAL-2274: Antiadalimumab antibodies in pediatric rheumatology patients. A pilot experience
por: Murias Loza, S, et al.
Publicado: (2013)

AZD9773 is a novel and potent anti-TNFα polyclonal ovine immune Fab
por: Newham, P, et al.
Publicado: (2011)

Tissue oxygen monitoring leads to lower rates of blood transfusions
por: Loukas, A, et al.
Publicado: (2011)

PReS-FINAL-2347: Does switching anti-TNFΑ biologic agents an effective option in childhood chronic uveitis: the evidence from a systematic review and meta-analysis approach
por: Simonini, G, et al.
Publicado: (2013)

Safety and efficacy of biological therapy with TNF-inhibitors and non TNF-inhibitors in a cohort of young adults affected by juvenile idiopathic arthritis (JIA): data from a single centre experience
por: Lorenzo, Ceri, et al.
Publicado: (2011)

Relative overexpression of membrane-bound versus soluble TNF in spondyloarthritis
por: Ambarus, Carmen A, et al.
Publicado: (2012)

The effects of anti–TNF agents on the expansion of T helper-type 17 cells driven by lipopolysaccharide-stimulated monocytes
por: Fossati, Gianluca, et al.
Publicado: (2012)

An immune surveillance model to monitor the response to neo-adjuvant chemotherapy treatment in breast cancer patients
por: Bernal-Estévez, David A, et al.
Publicado: (2015)

Response of pediatric uveitis to TNFα inhibitors
por: Lerman, Melissa A, et al.
Publicado: (2012)

Monitoring the efficacy of the cleaning and disinfection process for flexible endoscopes by quantification of multiple biological markers
por: Bommarito, M, et al.
Publicado: (2015)

In vitro and in vivo determination of anti-TNFα activity in canine plasma from donors subject to preconditioning with endotoxin
por: Kotiw, Michael, et al.
Publicado: (2007)

PReS-FINAL-2026: Glucose and lipid metabolism in children with juvenile idiopathic arthritis treated with anti-TNF-alpha
por: Christensen, AE, et al.
Publicado: (2013)

Activation of endothelial damage by TNFα and IFNγ in ischemia/reperfusion injury and systemic inflammation
por: Golovkin, A, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_9353l2tsi5aabae0k612j542o5